Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
BACKGROUND Quantitative fluorodeoxyglucose positron emission tomography (FDG-PET) biomarkers are associated with prognosis following stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (ES-NSCLC); however, their relationship with patterns of failure remains poorly defined. We evaluated the...